ArticleJCEM case reports2025
Transient Blindness in Metformin-associated Lactic Acidosis: Resolution With Supportive Care.
Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Potential Involvement of Redox and Inflammatory Signalling in the Antihyperglycemic and Antioxidant Effects of Harmaline in Male Mice With Type 2 Diabetes.Endocrinology, diabetes & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metformin remains the first-line pharmacologic treatment for type 2 diabetes mellitus due to its well-established efficacy and safety profile. However, a rare but serious complication is metformin-associated lactic acidosis (MALA), which carries a mortality rate of up to 36.2% in hospitalized patients. Those with chronic kidney disease and cardiovascular comorbidities are particularly vulnerable to severe outcomes. Among the rare manifestations of MALA is complete bilateral blindness, which typically requires urgent hemodialysis for reversal. Here, we present a case of MALA-induced blindness that was unexpectedly reversed through supportive medical management alone, prior to hemodialysis. This case underscores the critical role of early recognition and intervention by intensive care physicians in optimizing MALA outcomes. Further studies are warranted to elucidate the effects of MALA on the visual pathways, particularly the susceptibility of retinal cells and photoreceptors to metformin toxicities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.